HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Genetic linkage between the collagen type VII gene COL7A1 and pretibial epidermolysis bullosa with lichenoid features.

Abstract
Pretibial epidermolysis bullosa is a rare form of dominant dystrophic epidermolysis bullosa. The disease was diagnosed after considerable delay in a large Belgian family and was remarkable for its late age at onset and its misleading clinical presentation in the proband, which strongly resembled keratosis lichenoides chronica. Both recessively and dominantly inherited forms of dystrophic epidermolysis bullosa have been shown to be linked to the collagen type VII gene, COL7A1. Two-point linkage analysis with two intragenic polymorphisms (PvuII, AluI) in COL7A1 was performed. Strong genetic linkage between the disease in this family and COL7A1 was demonstrated by a lod score of 4.45 (theta = 0) for the AluI polymorphism. The observed intrafamilial variability of clinical phenotypes contradicts the presently proposed classification of dominantly inherited dystrophic epidermolysis bullosa.
AuthorsJ M Naeyaert, L Nuytinck, S De Bie, H Beele, A Kint, A De Paepe
JournalThe Journal of investigative dermatology (J Invest Dermatol) Vol. 104 Issue 5 Pg. 803-5 (May 1995) ISSN: 0022-202X [Print] United States
PMID7738360 (Publication Type: Journal Article)
Chemical References
  • Collagen
Topics
  • Adult
  • Aged
  • Alleles
  • Child
  • Collagen (genetics)
  • Epidermolysis Bullosa Dystrophica (genetics)
  • Female
  • Genes, Dominant
  • Genetic Linkage
  • Haplotypes
  • Humans
  • Leg Dermatoses (etiology, genetics)
  • Lichenoid Eruptions (etiology, genetics)
  • Male
  • Middle Aged
  • Pedigree
  • Phenotype
  • Polymorphism, Genetic
  • Tibia

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: